| Malik Nasir Baz, MD | |
|
7471 N Fresno St, Fresno, CA 93720-2457 | |
| (559) 436-4500 | |
| Not Available |
| Full Name | Malik Nasir Baz |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 51 Years |
| Location | 7471 N Fresno St, Fresno, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114923307 | NPI | - | NPPES |
| ZZZ21572Z | Other | CA | PTAN FOR ALL OFFICE LOCATIONS: BAZ ALLERGY, ASTHMA & SINUS CENTER |
| GR0043790 | Medicaid | CA | |
| 1114923307 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | A35393 (California) | Primary |
| 208000000X | Pediatrics | A35393 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baz Allergy Asthma And Sinus Center Inc | 6507770716 | 20 |
News Archive
For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.
Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable to finding a donor who can provide a perfect match of common tissue types, according to Be the Match®, a movement that engages the public to help patients in need of bone marrow or umbilical cord blood transplants.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's sapacitabine (CYC682) product candidate for the treatment of both acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
A University of Cincinnati (UC) study provides new evidence that drinking large amounts of beverages containing fructose adds body fat, and might explain why sweetening with fructose could be even worse than using other sweeteners.
› Verified 9 days ago
| Entity Name | Baz Allergy Asthma & Sinus Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710906995 PECOS PAC ID: 6507770716 Enrollment ID: O20031112000791 |
News Archive
For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.
Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable to finding a donor who can provide a perfect match of common tissue types, according to Be the Match®, a movement that engages the public to help patients in need of bone marrow or umbilical cord blood transplants.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's sapacitabine (CYC682) product candidate for the treatment of both acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
A University of Cincinnati (UC) study provides new evidence that drinking large amounts of beverages containing fructose adds body fat, and might explain why sweetening with fructose could be even worse than using other sweeteners.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Malik Nasir Baz, MD 7471 N Fresno St, Fresno, CA 93720-2457 Ph: (559) 436-4500 | Malik Nasir Baz, MD 7471 N Fresno St, Fresno, CA 93720-2457 Ph: (559) 436-4500 |
News Archive
For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.
Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable to finding a donor who can provide a perfect match of common tissue types, according to Be the Match®, a movement that engages the public to help patients in need of bone marrow or umbilical cord blood transplants.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's sapacitabine (CYC682) product candidate for the treatment of both acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
A University of Cincinnati (UC) study provides new evidence that drinking large amounts of beverages containing fructose adds body fat, and might explain why sweetening with fructose could be even worse than using other sweeteners.
› Verified 9 days ago
Dr. Rabinder Singh Sidhu, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7151 N Cedar Ave, Suite #103, Fresno, CA 93720 Phone: 559-325-7775 Fax: 559-325-7505 | |
Kelvin Gin Sun Lee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4500 | |
Dr. Kellie Jane Lim, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7471 N Fresno St, Fresno, CA 93720 Phone: 559-436-4500 Fax: 559-436-0500 | |
Dr. Lauren Shin Hiyama, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7471 N Fresno St, Fresno, CA 93720 Phone: 559-436-4500 Fax: 559-261-1526 | |
Sudeep Singh, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7011 N Howard, #201, Fresno, CA 93720 Phone: 559-431-9571 Fax: 559-431-4721 | |
Naveena R. Bobba, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 276 W Bluff Ave, Fresno, CA 93711 Phone: 310-486-2839 |